Genvor to Present at the Life Sciences Virtual Investor Forum December 11th

About this update from Genvor Incorporated

[{"type":"image","alt":"Virtual Investor Conferences; Genvor, Inc.","displaySize":"","headline":null,"caption":"Virtual Investor Conferences; Genvor, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":200,"url":"https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wFNFO9V7weOyJzKv3Grwwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI4MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc","width":300,"height":200}},"lazy":false},{"type":"text","content":"Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com","length":140,"tagName":"p"},{"type":"text","content":"WOODLAND, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, today announced that Chad Pawlak, Chief Executive Officer, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on December 11th.","length":332,"tagName":"p"},{"type":"text","content":"DATE: December 11th TIME: 12:30 pm ETLINK: REGISTER HEREAvailable for 1x1 meetings following the presentation. Schedule 1x1 Meetings here","length":145,"tagName":"p"},{"type":"text","content":"This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.","length":270,"tagName":"p"},{"type":"text","content":"It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.","length":137,"tagName":"p"},{"type":"text","content":"Learn more about the event at www.virtualinvestorconferences.com.","length":65,"tagName":"p"},{"type":"text","content":"Recent Company Highlights","length":25,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Expanded to 5 issued U.S. patents with 2 pending applications and 4 additional applications in preparation, plus international filings in Canada, Mexico, and China, providing comprehensive IP protection through 2038 for proprietary peptide technologies includin...

More updates from Genvor Incorporated